Among the millions quietly reshaped by long COVID, older women face a particular burden — one that may now be partially illuminated by something as ordinary as a blood test. Researchers in Chicago have found that elevated white blood cell counts predict the severity of long COVID symptoms in postmenopausal women, suggesting that inflammation, whether sparked by infection or already smoldering before it arrived, may be the hidden architect of prolonged suffering. The finding does not yet offer a cure, but it offers something medicine often undervalues: a way to see who is most at risk before th
UPI News
· Jan 29, 2025
· health
· 2 min de leitura
High
Apuração: Verificado
Blood test may predict long COVID severity in older women, study finds
Long COVID significantly affects quality of life and causes severe disability, with particularly pronounced cognitive impairment in postmenopausal women.
◉
Health & Medicine
8293 artigos relacionados
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% correspondência
Anaplasmosis cases rising in eastern Canada; doctors urge early treatm…
Lethbridge News Now · 99% correspondência
Antengene Posts 71% Revenue Growth on Breakthrough Cancer Drug Data
The Manila Times · 99% correspondência
First treatment trial launches for Bundibugyo Ebola strain in DRC
Google News · 99% correspondência
Finerenone Expands Hope for Non-Diabetic Kidney Disease Patients
The Hindu · 99% correspondência
Cobertura Relacionada
7NEWS · Aug 23
Model's Foot Cut Led to Heart Surgery, Baby Loss—Now Advocating for Better Diagnostics
Australian model Leah Ramsey lost her baby after a small foot cut triggered a rare heart infection that was repeatedly m…
Informanté · Aug 23 South Africa Shares FMD Vaccines as Region Strengthens Disease ControlsSouth Africa reports its largest-ever FMD outbreak is coming under control through accelerated vaccination and regional …
Al Jazeera · Aug 23 Solar telemedicine kiosks expand healthcare access across rural ChadSolar-powered telemedicine kiosks in rural Chad enable remote doctor consultations at a fraction of traditional travel c…
Inquirer.net · Aug 23 Prince Harry returns to UK amid family rifts, seeking reconciliation with monarchyPrince Harry and Meghan Markle are relocating back to Britain after six years in California, potentially signaling recon…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
🌎
Medical research on long COVID biomarkers has no direct geopolitical implications; this is a domestic health science finding without international relations consequences.
Escalation Risk
low
Confidence
HIGH
Lente Econômica
📈
Blood test identifying long COVID severity could reduce healthcare costs through early intervention and targeted treatment, benefiting diagnostic and pharmaceutical sectors while potentially reducing long-term disability expenses.
Market Signal
bullish
Confidence
MED
Healthcare/Medical Services
Diagnostic Testing/Laboratory Services
Pharmaceutical/Therapeutics Development
Medical Device Manufacturing
Health Insurance
Occupational Health/Disability Management
Consumers gain access to inexpensive, non-invasive screening tool enabling early identification of severe long COVID risk, potentially reducing out-of-pocket costs for managing severe symptoms and improving quality of life through preventive interventions. Particularly beneficial for older women and those with limited healthcare access.
Potential for regulatory approval of leukocyte count as standard long COVID severity predictor; possible insurance coverage expansion for preventive testing; public health initiatives to screen high-risk populations; increased research funding for long COVID therapeutics; workplace disability policy adjustments based on early identification.